Researcher

Melissa Ng is currently a Senior Scientist I based at Singapore Immunology Network (SIgN), A*STAR. She received her PhD in Biomedical Sciences from University of California, San Francisco (UCSF) in 2019, where she worked on the development of fetal T cells and their role in immunotolerance in utero under Trevor Burt. Under the mentorship of Lai Guan Ng at SIgN, her postdoctoral work was focused on investigating neutrophil reprogramming in the cancer microenvironment in order to identify potential druggable targets for immunotherapeutic use. Her interest lies in utilising high dimensional techniques in unison with experimental methods to investigate big picture questions in biology.